MassBio’s State of Possible Conference brings together biotech executives, investors, and partners shaping the future of the life sciences ecosystem.

Veloxity will be attending to engage with companies navigating growth, operational scale-up, and development execution. Many of our conversations focus on how quality discipline, turnaround time and integrated lab operations support confident progress — especially as programs mature.

We enjoy connecting with teams looking for bioanalytical partners who combine speed with rigor and transparency.

Veloxity attendee: Shelly Robbins, Senior Director, Business Development

Attending State of Possible? Let’s connect to talk about scaling bioanalysis without slowing your programs.